Chong‐Ze Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chong‐Ze Yang has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Cheng‐Can Huang
Department of Neurology Affiliated Hospital of Youjiang Medical University for Nationalities Baise Guangxi Zhuang Autonomous Region People's Republic of China
1 shared publication- Lan‐Hui Qin
Department of Radiology The First Affiliated Hospital of Guangxi Medical University Nanning Guangxi Zhuang Autonomous Region People's Republic of China
1 shared publication - Miao Fan
Department of Radiology, Guangxi Hospital Division of The First Affiliated Hospital, Sun Yat-sen University, No. 3 Foziling Rd, Qingxiu District, Nanning 530022, Guangxi Zhuang Autonomous Region, People’s Republic of China
1 shared publication - Wei Lan
Guangxi University
1 shared publication Xiao‐Li Huang
Department of Radiology, Guangxi Hospital Division of the First Affiliated Hospital Sun‐Yat‐Sen University Nanning Guangxi Zhuang Autonomous Region People's Republic of China
1 shared publicationYing‐Xia Yang
Department of Radiology, Guangxi Hospital Division of the First Affiliated Hospital Sun‐Yat‐Sen University Nanning Guangxi Zhuang Autonomous Region People's Republic of China
1 shared publication
Latest Publications
- Open Access
- 8 May 2026
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 40 (12) , e70250
Causal Interplay Between Inflammatory Cytokines and Lipid Metabolites in Serous Ovarian Carcinoma: Insights From a Genetic Association Study
Background: The causal roles and interactions of inflammatory cytokines and metabolic reprogramming in serous ovarian carcinoma (SOC) remain unclear. This study explored their relationships using Mendelian randomization (MR). Methods: In this two‐sample MR analysis, GWAS data of inflammatory cytokines and blood metabolites were used as exposures, and SOC from the FinnGen consortium served as the outcome. Inverse variance weighted (IVW) was the primary MR method, supplemented by MR Egger, weighted median, simple mode, and weighted mode. Two‐step mediation MR was applied to evaluate whether specific metabolites mediated the effect of inflammatory cytokines on SOC. Sensitivity analyses, including heterogeneity and pleiotropy tests, were conducted to assess robustness. Results: Five inflammatory cytokines were identified as risk factors for SOC: CSF1 (OR = 1.69, 95% CI: 1.17–2.43), CXCL1 (OR = 1.40, 95% CI: 1.01–1.93), IL‐20 (OR = 1.86, 95% CI: 1.03–3.35), IL‐8 (OR = 1.61, 95% CI: 1.08–2.39), and VEGF‐A (OR = 1.24, 95% CI: 1.00–1.54). Furthermore, 1‐Palmitoyl‐GPG (16:0) potentially mediates the relationship between IL‐8 and SOC, explaining ~10% of the total effect. No pleiotropy or heterogeneity was detected. Conclusions: This two‐sample MR study provides preliminary genetic evidence that inflammatory cytokines contribute to SOC risk, with lipid metabolism partially mediating IL‐8 effects. These findings highlight the interplay between inflammation and metabolism in SOC pathogenesis and suggest potential biomarkers and therapeutic targets. Due to limited sample sizes and European‐only ancestry datasets, these findings require validation in larger, multi‐ancestry cohorts.
- 8 May 2026
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 40 (12) , e70250
Open AccessCausal Interplay Between Inflammatory Cytokines and Lipid Metabolites in Serous Ovarian Carcinoma: Insights From a Genetic Association Study
Background: The causal roles and interactions of inflammatory cytokines and metabolic reprogramming in serous ovarian carcinoma (SOC) remain unclear. This study explored their relationships using Mendelian randomization (MR). Methods: In this two‐sample MR analysis, GWAS data of inflammatory cytokines and blood metabolites were used as exposures, and SOC from the FinnGen consortium served as the outcome. Inverse variance weighted (IVW) was the primary MR method, supplemented by MR Egger, weighted median, simple mode, and weighted mode. Two‐step mediation MR was applied to evaluate whether specific metabolites mediated the effect of inflammatory cytokines on SOC. Sensitivity analyses, including heterogeneity and pleiotropy tests, were conducted to assess robustness. Results: Five inflammatory cytokines were identified as risk factors for SOC: CSF1 (OR = 1.69, 95% CI: 1.17–2.43), CXCL1 (OR = 1.40, 95% CI: 1.01–1.93), IL‐20 (OR = 1.86, 95% CI: 1.03–3.35), IL‐8 (OR = 1.61, 95% CI: 1.08–2.39), and VEGF‐A (OR = 1.24, 95% CI: 1.00–1.54). Furthermore, 1‐Palmitoyl‐GPG (16:0) potentially mediates the relationship between IL‐8 and SOC, explaining ~10% of the total effect. No pleiotropy or heterogeneity was detected. Conclusions: This two‐sample MR study provides preliminary genetic evidence that inflammatory cytokines contribute to SOC risk, with lipid metabolism partially mediating IL‐8 effects. These findings highlight the interplay between inflammation and metabolism in SOC pathogenesis and suggest potential biomarkers and therapeutic targets. Due to limited sample sizes and European‐only ancestry datasets, these findings require validation in larger, multi‐ancestry cohorts.